Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $364
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Humana (NYSE:HUM) but lowers the price target from $370 to $364.
August 01, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Humana but lowers the price target from $370 to $364.
The lowered price target from $370 to $364 suggests a slightly less optimistic outlook for Humana, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100